EERAIS MILLER: Open Payments
NPI 1346908399 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$112 in 6 payments from 5 companies in 2025. Trend: 2023 $554 · 2024 $1,398 · 2025 $112
Food & beverage: $112
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Organon LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: BREZTRI, NEXPLANON, REXULTI, VRAYLAR, CAPLYTA.
Industry payments across CA — which companies pay providers there.
